Skip to main content
. 2023 May 15;13:1122789. doi: 10.3389/fonc.2023.1122789

Figure 3.

Figure 3

Snapshot of lipid metabolic alterations and their molecular players in T-cell malignancies. Rewiring in various dimensions of lipid metabolisms is reported in clinical and preclinical studies with T-cell malignancies. Patient-derived cells (AML, ATL, CML, CTL, ETP-ALL, and T-LBL) or cell lines (Jurkat, EL-4, DL, HUT-78, K562, and MOLM-13) of T-cell cancers exhibit modulation in lipid metabolic players as well as their regulators.